Close

Company History

Picture

CARsgen reports Phase-I CAR-GPC3 T Cell HCC trial results at ASCO 2017 annual meeting

Jun 2017

Picture

CARsgen started CAR-CLD18.2 T cell clinical trial

May 2017

Picture

CARsgen opened its new 33,000 sq.ft. cGMP Facility in Shanghai

Apr 2017

Picture

CARsgen US entity opened in San Diego, CA

Jan 2017

Picture

CARsgen Shanghai cell facility started construction

Sept 2016

Picture

Series B of USD 30 M led by KTB.

Jan 2016

Picture

CARsgen entered into Strategic Partnership with Shanghai Cancer Institute

Sept 2015

Picture

CARsgen initiated world’s first Phase I CAR-GPC3 T Cell HCC trial

June 2015

Picture

CARsgen started its leading CAR-T clinical trial on GBM

May 2015

Picture

Series A of RMB 10 M by BVCF.

Nov 2014

Picture

CARsgen Therapeutics founded in JUKE Biopark, Shanghai

Oct 2014